**Author details**

Yukihiko Ueda Okinawa International University, Ginowan, Okinawa, Japan

\*Address all correspondence to: y.ueda@okiu.ac.jp

© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**47**

*Cognitive Function and Quality of Life of Muscular Dystrophy*

[9] Bushby KM, Appelton R, Anderson LV, Welch JL, Kelly P, Gardner-Medwin D. Deletion status and intellectual impairment in Duchenne muscular dystrophy. Developmental Medicine and Child Neurology. 1995;**37**:260-269

[10] Michalak M, Opas M. Function of dystrophin and dystrophin associated proteins. Current Opinion in Neurology.

[11] Ogasawara A. Downward shift in IQ in persons with Duchenne muscular dystrophy compared to those with spinal muscular atrophy. American Journal of Mental Retardation.

[12] Rapaport D, Passos-Bueno MR, Brandao L, Love D, Vainzof M, Zatz M. Apparent association of mental retardation and specific patterns of deletions screened with probes cf56a and cf23a in Duchenne muscular dystrophy. American Journal of Medical

Genetics. 1991;**39**:437-441

1992;**2**:371-378

[13] Billard C, Gillet P, Signoret J, Uicaut E, Bertand P, Fardeau M, et al. Cognitive functions in Duchenne muscular dystrophy: A reappraisal and comparison with spinal muscular atrophy. Neuromuscular Disorders.

[14] Dorman C, Hurley AD, D'Avignon J. Language and learning disorders of older boys with Duchenne muscular dystrophy. Developmental Medicine and Child Neurology. 1988;**30**:316-327

[15] Karagan NJ, Zellweger HU. Early verbal disability in children with Duchenne muscular dystrophy. Developmental Medicine and Child

[16] Marsh GG, Munsat TL. Evidence of early impairment of verbal intelligence in Duchenne muscular dystrophy.

Neurology. 1978;**20**:435-441

1997;**10**:436-442

1989;**93**:544-547

*DOI: http://dx.doi.org/10.5772/intechopen.86222*

[1] Orsini M, Andorinho de F, Ferreira A, Damm de Assis A, Magalhães T, Teixeira S, et al. Cognitive impairment in neuromuscular diseases: A systematic review. NI [Internet]. 2018 [cited 10 November 2018];**10**(2). Available from: https://www.pagepress.org/journals/ index.php/ni/article/view/7473

[2] Netterlund B et al. Disability, coping and quality of life in individuals with muscular dystrophy: A prospective study over five years. Disability and Rehabilitation. 2000;**22**:776-785

[3] Boström K, Ahlström G. Living with chronic deteriorating disease: The trajectory with muscular dystrophy over ten years. Disability and Rehabilitation.

[4] Ueda Y, Hirayama A, Fukuhara S, Akamine R, Miyagi C, Nakasone M, et al. Quality of life and related factors in inpatients of muscular dystrophy. Sogo Rehabilitation. 2014;**42**(12):

2004;**26**(17):1388-1398

1185-1190. (in Japanese)

2013;**23**:313-315

Shinkei. 1999;**51**:621-626

[8] Doorenweerd N, Straathof CS, Dumas EM, Spitali P, Ginjaar IB, Wokke BH, et al. Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy. Annals

of Neurology. 2014;**76**:403-411

[5] Anderson JL, Head SI, Rac C, Morley JW. Brain function in Duchenne muscular dystrophy. Brain. 2002;**125**:4-13

[6] Pane M, Messina S, Bruno C, D'Amico A, Villanova M, Brancalion B, et al. Duchenne muscular dystrophy and epilepsy. Neuromuscular Disorders.

[7] Konagaya M, Sakai M, Kuru S, Kato T, Yasuma F, Matsuoka Y. Evaluation of cranial CT findings of patients with muscular dystrophy: With a reference to cerebral vascular disease and cardiac complications(in Japanese). Nō to

**References**

*Cognitive Function and Quality of Life of Muscular Dystrophy DOI: http://dx.doi.org/10.5772/intechopen.86222*
